BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4405597)

  • 1. Imparied lymphocyte responsiveness in inflammatory bowel disease.
    Sachar DB; Taub RN; Brown SM; Present DH; Korelitz BI; Janowitz HD
    Gastroenterology; 1973 Feb; 64(2):203-9. PubMed ID: 4405597
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory bowel disease. Part II.
    Hansen R
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 4. II. Medical treatment of inflammatory bowel disease.
    Gray GM
    Calif Med; 1973 Nov; 119(5):21-4. PubMed ID: 4148269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunomodulation treatment of inflammatory bowel disease].
    Stave R
    Tidsskr Nor Laegeforen; 1984 Jan; 104(3):153-4. PubMed ID: 6142543
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective lymphocyte IgA production in inflammatory bowel disease.
    Holdstock G; Ershler WB; Krawitt EL
    Clin Immunol Immunopathol; 1982 Jul; 24(1):47-54. PubMed ID: 6125286
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine.
    Campbell AC; Skinner JM; Hersey P; Roberts-Thomson P; MacLennan IC; Truelove SC
    Clin Exp Immunol; 1974 Apr; 16(4):521-33. PubMed ID: 4468852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC
    J Maine Med Assoc; 1976 Jul; 67(7):206-14. PubMed ID: 9461
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

  • 13. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases].
    Ewe K
    Verh Dtsch Ges Inn Med; 1988; 94():178-84. PubMed ID: 2905098
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gastroenterology; 1973 Jul; 65(1):1-7. PubMed ID: 4720822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic inflammatory bowel diseases. No fear with powerful preventive drugs].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Nov; 142(45):18. PubMed ID: 11107819
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of inflammatory bowel disease, including use of immunosuppressive agents.
    Korelitz BI
    Clin Gastroenterol; 1980 May; 9(2):331-49. PubMed ID: 6104550
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro lymphocyte response to non-specific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gut; 1972 Apr; 13(4):320. PubMed ID: 5033849
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inflammatory diseases of the intestines].
    Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
    Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic inflammatory bowel diseases. Earlier transition to immunosuppressive drugs].
    Bischoff A
    MMW Fortschr Med; 2002 May; 144(18):10. PubMed ID: 12422699
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary function in patients with inflammatory bowel disease.
    Eade OE; Smith CL; Alexander JR; Whorwell PJ
    Am J Gastroenterol; 1980 Feb; 73(2):154-6. PubMed ID: 6104919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.